Publicações Científicas 2023 - Janeiro a Outubro

1. Fernandes RT, Teixeira GR, Mamere EC, Bandeira GA, Mamere AE. The 2021 World Health Organization classification of gliomas: an imaging approach. Radiol Bras. 2023;56(3):157-61. 10.1590/0100-3984.2022.0089-en.

2. Eskelinen M, Pulkkinen J, Selander T, Syrjänen K, Eskelinen M. Accuracy of Prediction Models in Diagnosis of Acute Diverticulitis. In Vivo. 2023;37(6):2597-608. 10.21873/invivo.13367.

3. Sousa LR, Oliveira AGS, Arantes A, Junqueira JGM, Alexandre GP, Severino VGP, et al. Acetogenins-Rich Fractions of Annona coriacea Suppress Human Glioblastoma Viability and Migration by Regulating Necroptosis and MMP-2 Activity In Vitro. Molecules. 2023;28(9). 10.3390/molecules28093809.

4. Vieira AGS, Puthenpura V, Krailo M, Fallahazad N, Brougham MFH, Murray MJ, et al. Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium. Pediatr Blood Cancer. 2023:e30426. 10.1002/pbc.30426.

5. Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, et al. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions. N Engl J Med. 2023. 10.1056/NEJMoa2306441.

6. Pires RC, Gama RR, da Silveira Júnior PS, Teixeira FM, Santos CR, de Castro Capuzzo R. Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center. Eur Arch Otorhinolaryngol. 2023. 10.1007/s00405-023-08180-w.

7. Pires SF, Barros JS, Costa SSD, Carmo GBD, Scliar MO, Lengert AVH, et al. Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. Int J Mol Sci. 2023;24(13). 10.3390/ijms241310463.

8. Vieira R, Sant’Anna D, Laus AC, Reis RM. Ancestry and self-reported race in Brazilian breast cancer women. Rev Assoc Med Bras (1992). 2023;69(12):e20230767. 10.1590/1806-9282.20230767.

9. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, et al. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 2023;8(9):e691-e700. 10.1016/s2468-2667(23)00131-7.

10. Bizzarri N, Dostálek L, van Lonkhuijzen L, Giannarelli D, Lopez A, Falconer H, et al. Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy. Obstet Gynecol. 2023;141(1):207-14. 10.1097/aog.0000000000005026.

11. Zampieri FG, Cavalcanti AB, Taniguchi LU, Lisboa TC, Serpa-Neto A, Azevedo LCP, et al. Attributable mortality due to nosocomial sepsis in Brazilian hospitals: a case-control study. Ann Intensive Care. 2023;13(1):32. 10.1186/s13613-023-01123-y.

12. Diab A, Gogas H, Sandhu S, Long GV, Ascierto PA, Larkin J, et al. Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. J Clin Oncol. 2023:Jco2300172. 10.1200/jco.23.00172.

13. Cho BC, Lee JS, Wu YL, Cicin I, Dols MC, Ahn MJ, et al. Bintrafusp alfa versus pembrolizumab in patients with treatment-naive, PD-L1-high advanced non-small cell lung cancer: a randomized, open-label, phase 3 trial. J Thorac Oncol. 2023. 10.1016/j.jtho.2023.08.018.

14. Campanella NC, Gomes INF, Alves ALV, Leal LF, Evangelista AF, Rosa MN, et al. Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis. Cancer Cell Int. 2023;23(1):256. 10.1186/s12935-023-03102-6.

15. Tostes K, Siqueira AP, Reis RM, Leal LF, Arantes LMBR. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability. International Journal of Molecular Sciences. 2023;24(15):11887. 10.3390/ijms241511887.

16. Silva VAO, Rosa MN, Gomes INF, Vital PDS, Alves ALV, Evangelista AF, et al. Bio-Prospecting of Crude Leaf Extracts from Thirteen Plants of Brazilian Cerrado Biome on Human Glioma Cell Lines. Molecules. 2023;28(3). 10.3390/molecules28031394.

17. Assem NZ, Pazmiño VFC, Rodas MAR, Caliente EA, da Silva Dalben G, Soares S, et al. Bone Substitutes Graft for Regeneration of the Anterior Maxillary Alveolar Process: A Systematic Review. J Oral Implantol. 2023;49(1):102-13. 10.1563/aaid-joi-D-22-00014.

18. Hermoza AD, de Macêdo Matsushita G, Dos Santos MH, Schmidt RL, Dos Reis R, da Cunha Andrade CEM. Botryoid embryonal rhabdomyosarcoma of the cervix: A case report. Int J Surg Case Rep. 2023;102:107858. 10.1016/j.ijscr.2022.107858.

19. Correa MEP, Granzotto FCN, Innocentini L, Reis TC, de Lima EM, Varanda RF, et al. Brazilian dental consensus on dental management in hematopoietic stem cell transplantation – Part I – pre-HSCT. Hematol Transfus Cell Ther. 2023. 10.1016/j.htct.2023.04.001.

20. da Costa Vieira RA, Ching AW, de Oliveira-Junior I. Breast reconstruction for locally advanced breast cancer previously submitted to mastectomy and an ipsilateral thoracoabdominal dermofat (ITADE) flap. Breast Dis. 2023;42(1):229-32. 10.3233/bd-220057.

21. Dutra VGP, Silva J, Jomar RT, Silveira HCS, Muzi CD, Guimarães RM. Burden of occupational cancer in Brazil and federative units, 1990-2019. Rev Bras Epidemiol. 2023;26:e230001. 10.1590/1980-549720230001.

22. Paiva BSR, Lourenço BM, Prata HM, Valentino TCO, Oliveira MA, Santos Neto MFD, et al. Burial or cremation? Factors associated with preferences among patients with cancer in Brazil: a cross-sectional study. Sao Paulo Med J. 2023;141(6):e2022441. 10.1590/1516-3180.2022.0441.R1.13022023.

23. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F. Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Med. 2023. 10.1002/cam4.6259.

24. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani J. Cancer survival in the northwestern of São Paulo State, Brazil: A population-based study. Cancer Epidemiol. 2023;83:102339. 10.1016/j.canep.2023.102339.

25. Paiva CE, Paiva BSR. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. Oncologist. 2023. 10.1093/oncolo/oyad284.

26. Correa Porto CRC, Longatto-Filho A, De Almeida BC, Bonetti TC, Kamaiurá SFA, Diaz RS, et al. Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus infections of lower genital tract of Indigenous women from Xingu Indigenous Park. Rural Remote Health. 2023;23(3):7126. 10.22605/rrh7126.

27. Vigorito AC, Miranda ECM, Colturato VAR, Funke VAM, Fatobene G, Mariano L, et al. Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival. Transplant Cell Ther. 2023. 10.1016/j.jtct.2023.01.007.

28. Afonso J, Barbosa A, Pastrez PRA, Bonatelli M, da Costa RFA, Pinheiro C, et al. Clinical and Prognostic Impact of the Warburg Effect in Esophageal Carcinoma: Monocarboxylate Transporters as Candidates for Therapeutic Targeting. Pathobiology. 2023. 10.1159/000528562.

29. de Oliveira LC, Rosa K, Gaspar T, Paiva BSR, Paiva CE, Peres WAF. Clinical usefulness of the Patient-Generated Subjective Global Assessment and modified Glasgow Prognostic Score in decision making concerning the indication of enteral nutritional therapy in patients with incurable cancer receiving palliative care. Nutrition. 2023;112:112057. 10.1016/j.nut.2023.112057.

30. Bermudi PMM, Pellini ACG, Diniz CSG, Ribeiro AG, de Aguiar BS, Failla MA, et al. Clusters of high-risk, low-risk, and temporal trends of breast and cervical cancer-related mortality in São Paulo, Brazil, during 2000-2016. Ann Epidemiol. 2023;78:61-7. 10.1016/j.annepidem.2022.12.009.

31. Ribeiro AG, Costa AMd, Pereira TF, Guimarães DP, Fregnani JHTG. Colorectal cancer spatial pattern in the northeast region of São Paulo, Brazil. Global Epidemiology. 2023;5:100097. 10.1016/j.gloepi.2022.100097.

32. Bravo Perina L, Faria Gomes IN, Alcantara Pelloso AR, Silva VAO, Rebolho Batista Arantes LM, Eliseo Melendez M. Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines. Sci Rep. 2023;13(1):18023. 10.1038/s41598-023-44888-9.

33. Lima AB, Dos Reis MB, Matsushita M, Dos Reis MT, de Oliveira MA, Reis RM, et al. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population. Cancer Med. 2023. 10.1002/cam4.6224.

34. Bell M, Verberckmoes B, Devolder J, Vermandere H, Degomme O, Guimarães YM, et al. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex II HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples. Microbiol Spectr. 2023:e0008123. 10.1128/spectrum.00081-23.

35. Trevizan FB, Paiva CE, Julião M, de Oliveira Valentino TC, Miwa MU, Mingardi M, et al. Comprehension and Decision-Making Capacity Questionnaire About Palliative Care and Advance Care Planning: A Delphi Study. J Palliat Care. 2023;38(1):41-51. 10.1177/08258597221128676.

36. Santos MMD, Frasson AL, Silva VDD, Maciel ACA, Watte G, Werutsky G, et al. Core Needle Biopsy Accuracy for Androgen Receptor Expression in Invasive Breast Cancer. Rev Bras Ginecol Obstet. 2023;45(9):e535-e41. 10.1055/s-0043-1772486.

37. Lourenção M, Arruda GV, Rocha LP, Galendi JSC, de Oliveira JC, Jacinto AA. Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system. BMC Health Serv Res. 2023;23(1):592. 10.1186/s12913-023-09397-5.

38. Salaroli LB, Ferreira JRS, Prado CBD, De Podestá OPG, Carvalho AL, Mercante A, et al. Cumulative Coffee Consumption as a Protective Factor for Head and Neck Cancer in Brazil. Nutr Cancer. 2023;75(1):228-35. 10.1080/01635581.2022.2106377.

39. Lugo LZA, Puga MAM, Jacob CMB, Padovani CTJ, Nocetti MC, Tupiná MS, et al. Cytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus. PLoS One. 2023;18(3):e0279390. 10.1371/journal.pone.0279390.

40. Gobbi MF, Ferreira MH, de Carvalho DLC, Silva GBL, Macari KSM, Neves LJ, et al. Dental consensus on HSCT – Part II: dental Care during HSCT. Hematol Transfus Cell Ther. 2023. 10.1016/j.htct.2023.04.003.

41. Santos P, Granzotto FCN, Antunes HS, de Lima EM, Varanda RF, Maccari K, et al. Dentistry consensus on HSCT – Part III: Special topics – Dentistry on HSCT. Hematol Transfus Cell Ther. 2023. 10.1016/j.htct.2023.04.004.

42. Dos Reis LR, Luiz MT, Sábio RM, Marena GD, Di Filippo LD, Duarte JL, et al. Design of rapamycin and resveratrol coloaded liposomal formulation for breast cancer therapy. Nanomedicine (Lond). 2023. 10.2217/nnm-2022-0227.

43. Pereira TF, Aranha VJ, Waldvogel BC, da Costa AM, Tavares Guerreiro Fregnani JH. Deterministic linkage for improving follow-up time in a Brazilian population-based cancer registry. Sci Rep. 2023;13(1):4816. 10.1038/s41598-023-31303-6.

44. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. Diagnostic Accuracy of Fecal Immunochemical Test (FIT) in Bleed-positive and Bleed-negative Colorectal Cancer (CRC) Among a Cohort of 5,090 Subjects who Participated in the Colorectal Neoplasia (CRN) Screening in Brazil. Anticancer Res. 2023;43(4):1569-80. 10.21873/anticanres.16307.

45. Causin RL, Sussuchi da Silva L, Leal LF, Possati-Resende JC, Evangelista AF, Matsushita GM, et al. The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology. Cancer Cytopathol. 2023. 10.1002/cncy.22704.

46. Marques RF, Moreno DA, da Silva L, Leal LF, de Paula FE, Santana I, et al. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Front Immunol. 2023;14:1062856. 10.3389/fimmu.2023.1062856.

47. Untergasser A, Hellemans J, Pfaffl MW, Ruijter JM, van den Hoff MJB, Dragomir MP, et al. Disclosing quantitative RT-PCR raw data during manuscript submission:a call for action. Mol Oncol. 2023. 10.1002/1878-0261.13418.

48. Kelner M, Carvalho da Silva B, Montella T, Aguiar PN, Jr., Lopes G, Ferreira CG, et al. Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System. Value Health Reg Issues. 2023;33:1-6. 10.1016/j.vhri.2022.08.004.

49. Andrade DAP, Veneziani AC, Paiva CE, Dos Reis R, Filho CAF, Sanches AON, et al. Discrepancies in breast cancer’s oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study. Front Oncol. 2023;13:1169982. 10.3389/fonc.2023.1169982.

50. Ribeiro Junior HL, Gonçalves PG, Moreno DA, Goes JVC, de Oliveira RTG, Montefusco-Pereira CV, et al. Discrepancy in transcriptomic profiling between CD34 + stem cells and primary bone marrow cells in myelodysplastic neoplasm. Leuk Res. 2023;129:107071. 10.1016/j.leukres.2023.107071.

51. Cavagna RO, Pinto IA, Escremim de Paula F, Berardinelli GN, Sant’Anna D, Santana I, et al. Disruptive and truncating TP53 mutations are associated with African-ancestry and worse prognosis in Brazilian patients with lung adenocarcinoma. Pathobiology. 2023. 10.1159/000530587.

52. Pires SF, de Barros JS, da Costa SS, de Oliveira Scliar M, Van Helvoort Lengert A, Boldrini É, et al. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development. Mol Genet Genomics. 2023. 10.1007/s00438-023-02010-8.

53. Vieira R, Bailão-Junior A, de Oliveira-Junior I. Does breast oncoplastic surgery improve quality of life? Front Oncol. 2023;12:1099125. 10.3389/fonc.2022.1099125.

54. Goncalves BT, Dos Reis R, Ribeiro R, Moretti-Marques R, Schamme FK, Oliveira GS, et al. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer? Int J Gynecol Cancer. 2023;33(10):1548-56. 10.1136/ijgc-2023-004555.

55. Poma MAM, Ribeiro Junior HL, Costa EA, Paier CRK, Brasil LL, Lima LB, et al. Effect of CYB2B6 (c.516G>T), CYP2C9 (c.1075A>C) and UGT1A9 (c.98T>C) polymorphisms on propofol pharmacokinetics in patients submitted to colonoscopy: a cohort study. Postgrad Med J. 2023;99(1170):286-95. 10.1136/postgradmedj-2021-141375.

56. Cruz AR, Minicucci EM, Betini M, Almeida-Lopes L, Tieghi Neto V, Cataneo AJM. Efficacy of photobiomodulation in the treatment of oral mucositis in patients undergoing antineoplastic therapy: systematic review and meta-analysis. Support Care Cancer. 2023;31(12):645. 10.1007/s00520-023-08105-7.

57. Zanon JR, Durante H, Nóbrega LM, Accorsi G, Pedrão PG, Dos Reis R. Emphysematous pyelonephritis after urinary diversion by percutaneous nephrostomy in patient with advanced cervical cancer: A case report. SAGE Open Med Case Rep. 2023;11:2050313×231182532. 10.1177/2050313×231182532.

58. Hayashi MC, Sarri AJ, Pereira P, Rocha MM, Zequi SC, Machado MT, et al. Ergonomic risk assessment of surgeon’s position during radical prostatectomy: Laparoscopic versus robotic approach. J Surg Oncol. 2023. 10.1002/jso.27419.

59. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 2023. 10.1007/s10552-023-01812-w.

60. Arns B, Agani C, Sesin GP, Horvath JDC, Fogazzi DV, Romeiro Silva FK, et al. Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e79. 10.1017/ash.2023.136.

61. Ferreira D, Santos-Pereira C, Costa M, Afonso J, Yang S, Hensel J, et al. Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomater Adv. 2023;154:213643. 10.1016/j.bioadv.2023.213643.

62. Ferreira J, Afonso J, Carneiro AL, Vila I, Cunha C, Roque S, et al. Exploring the Diversity of Visceral, Subcutaneous and Perivascular Adipose Tissue in a Vascular Surgery Population. J Cardiovasc Dev Dis. 2023;10:2-17. 10.3390/jcdd10070271.

63. Komoto TT, Nishimura FG, Evangelista AF, Freitas AJAd, Silva Gd, Silva Junior WA, et al. Exploring the Therapeutic Potential of Trans-Chalcone: Modulation of MicroRNAs Linked to Breast Cancer Progression in MCF-7 Cells. Int J Mol Sci. 2023:1-17.

64. Zantut-Wittmann DE, Laus AC, Moreno DA, Barreto IS, Moma CA, Maia FFR, et al. Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter. Am J Med Sci. 2023. 10.1016/j.amjms.2023.03.019.

65. Pereira LL, Veiga Siqueira Amorim D, Brito Sampaio W, Almeida Cruz Azevêdo T, Bispo Pereira Cardoso V, Barreto Lemos F, et al. Factors Associated with Periodontitis in Patients with and without HIV. Int J Dent. 2023;2023:9929835. 10.1155/2023/9929835.

66. de Oliveira-Junior I, da Costa Vieira RA, Biller G, Sarri AJ, da Silva FCB, Nahás EAP. Factors associated with unsatisfactory cosmetic results in oncoplastic surgery. Front Oncol. 2023;13:1071127. 10.3389/fonc.2023.1071127.

67. Eskelinen M, Meklin J, Guimarães DP, Selander T, Syrjänen K, Eskelinen M. Fecal Immunochemical Test (FIT) in Triage of Bleed-positive (Crab+) and Bleed-negative Colorectal Adenoma (Crab-) Patients in Colorectal Neoplasia Screening. Anticancer Res. 2023;43(8):3517-28. 10.21873/anticanres.16529.

68. Pessini SA, Carvalho JP, Reis RD, Filho A, Primo W. Fertility preservation in gynecologic cancer patients. Rev Bras Ginecol Obstet. 2023;45(3):161-8. 10.1055/s-0043-1768564.

69. Ritter J, Allen S, Cohen PD, Fajardo AF, Marx K, Loggetto P, et al. Financial hardship in families of children or adolescents with cancer: a systematic literature review. Lancet Oncol. 2023;24(9):e364-e75. 10.1016/s1470-2045(23)00320-0.

70. Borges DP, Dos Santos R, Velloso ERP, Ribeiro Junior HL, Larripa IB, Camacho MF, et al. Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome. Hematol Transfus Cell Ther. 2023;45(2):147-53. 10.1016/j.htct.2021.08.002.

71. Mendes AI, Fraga AG, Peixoto MJ, Aroso I, Longatto-Filho A, Marques AP, et al. Gellan gum spongy-like hydrogel-based dual antibiotic therapy for infected diabetic wounds. Bioengineering & translational medicine. 2023;8(2):1-13. 10.1002/btm2.10504.

72. De Marchi P, Leal LF, da Silva LS, Cavagna RO, da Silva FAF, da Silva VD, et al. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Transl Oncol. 2023;39:101818. 10.1016/j.tranon.2023.101818.

73. da Costa Vieira RA, Sant’Anna D, Laus AC, Bacchi CE, Silva RJC, de Oliveira-Junior I, et al. Genetic Ancestry of 1127 Brazilian Breast Cancer Patients and Its Correlation With Molecular Subtype and Geographic Region. Clin Breast Cancer. 2023. 10.1016/j.clbc.2023.04.001.

74. Garcia FAO, Evangelista AF, Mançano BM, Moreno DA, Berardinelli GN, de Paula FE, et al. Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing. Cold Spring Harb Mol Case Stud. 2023;9(1). 10.1101/mcs.a006245.

75. Guimarães Ribeiro A, Ferlay J, Piñeros M, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Geographic variations in cancer incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Epidemiol. 2023;85:102403. 10.1016/j.canep.2023.102403.

76. Afonso J, Gonçalves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, et al. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy. Cancers (Basel). 2023;15(3). 10.3390/cancers15030982.

77. de Oliveira Klein M, Francisco LFV, Gomes INF, Serrano SV, Reis RM, Silveira HC. Hazard assessment of antineoplastic drugs and metabolites using cytotoxicity and genotoxicity assays. Mutation Research/Genetic Toxicology Environmental Mutagenesis. 2023;892:503704. 10.1016/j.mrgentox.2023.503704.

78. Moehler M, Xiao H, Blum SI, Elimova E, Cella D, Shitara K, et al. Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649. J Clin Oncol. 2023:Jco2300170. 10.1200/jco.23.00170.

79. Moreno DA, Bonatelli M, Antoniazzi AP, de Paula FE, Leal LF, Garcia FAO, et al. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Front Oncol. 2023;13:1237170. 10.3389/fonc.2023.1237170.

80. Villela NC, Seber A, Macedo C, Zecchin VG, Guimarães R, Faria TMV, et al. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors – experience of two Brazilian pediatric centers. Pediatr Hematol Oncol. 2023:1-15. 10.1080/08880018.2023.2187497.

81. Atallah FC, Caruso P, Nassar APJ, Torelly AP, Amendola CP, Salluh JIF, et al. High-value care for critically ill oncohematological patients: what do we know thus far? Crit Care Sci. 2023;35(1):84-96. 10.5935/2965-2774.20230405-en.

82. Teixeira AP, Haddad W, Jr., Barreto LO, Secaf A, Mermejo LM, Lucchesi FR, et al. Histogram analysis in the differentiation between adrenal adenomas and pheochromocytomas: the value of a single measurement. Radiol Bras. 2023;56(2):59-66. 10.1590/0100-3984.2022.0067.

83. Paiva CE, Bonilla-Sierra P, Tripodoro VA, Rodríguez-Nunez A, De Simone G, Rodriguez LH, et al. How to Advance Palliative Care Research in South America? Findings From a Delphi Study. J Pain Symptom Manage. 2023;65(3):193-202. 10.1016/j.jpainsymman.2022.11.020.

84. Zanon MF, Scapulatempo-Neto C, Gama RR, Marques MMC, Reis RM, Evangelista AF. Identification of MicroRNA Expression Profiles Related to the Aggressiveness of Salivary Gland Adenoid Cystic Carcinomas. Genes (Basel). 2023;14(6). 10.3390/genes14061220.

85. Gholami S, Chamorro-Petronacci C, Pérez-Sayáns M, Suárez Peñaranda J, Longatto-Filho A, Baltazar F, et al. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study. J Appl Oral Sci. 2023;31:e20220461. 10.1590/1678-7757-2022-0461.

86. Solla Negrao EM, Cabello C, Conz L, Mauad EC, Zeferino LC, Vale DB. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area. J Med Screen. 2023;30(1):42-6. 10.1177/09691413221122055.

87. Martins TR, Witkin SS, Mendes-Correa MC, Godoy AS, Cury L, Balancin ML, et al. Impact of the covid-19 pandemic on cervical cancer screening in São Paulo State, Brazil. Acta Cytol. 2023. 10.1159/000529249.

88. Francisco LFV, Baldivia DDS, Crispim BDA, Baranoski A, Klafke S, Dos Santos EL, et al. In vitro evaluation of the cytotoxic and genotoxic effects of Al and Mn in ambient concentrations detected in groundwater intended for human consumption. Ecotoxicol Environ Saf. 2023;264:115415. 10.1016/j.ecoenv.2023.115415.

89. Chavan R, Baraldo S, Rajput S. Inclusion of Patients With Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention. Gastroenterology. 2023. 10.1053/j.gastro.2023.05.011.

90. Monção CC, Scrideli CA, Andrade AF, Viapiano MS, Carlotti CG, Moreno DA, et al. Indisulam Reduces Viability and Regulates Apoptotic Gene Expression in Pediatric High-Grade Glioma Cells. J Biomedicines. 2023;11(1):68. 10.3390/biomedicines11010068.

91. Ferreira J, Carneiro A, Vila I, Silva C, Cunha C, Longatto-Filho A, et al. Inflammation and Loss of Skeletal Muscle Mass in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2023;88:164-73. 10.1016/j.avsg.2022.07.009.

92. Rocha BMM, Dolan RD, Paiva CE, McGovern J, Paiva BSR, Preto DD, et al. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer. J Pain Symptom Manage. 2023;65(4):348-57. 10.1016/j.jpainsymman.2022.11.021.

93. Pastrez PRA, Barbosa AM, Mariano VS, Causin RL, Castro AG, Torrado E, et al. Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2023;15(7). 10.3390/cancers15071997.

94. Singer S, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, Hammerlid E, et al. International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34. Thyroid. 2023. 10.1089/thy.2023.0221.

95. Pombo-de-Oliveira MS, Petridou ET, Karalexi MA, Junqueira MER, Braga FHP, Bouzas LF, et al. The Interplay of Cesarean-Section Delivery and First-Birth Order as Risk Factors in Acute Lymphoblastic Leukemia. Cancer Epidemiol Biomarkers Prev. 2023;32(3):371-9. 10.1158/1055-9965.Epi-22-0664.

96. Aguiar BS, Pellini ACG, Rebolledo EAS, Ribeiro AG, Diniz CSG, Bermudi PMM, et al. Intra-urban spatial variability of breast and cervical cancer mortality in the city of São Paulo: analysis of associated factors. Rev Bras Epidemiol. 2023;26:e230008. 10.1590/1980-549720230008.2.

97. Colombo AL, Bergamasco MD, Nouér SA, Oliveira ECPT, Pasqualotto AC, de Queiroz-Telles F, et al. Invasive Aspergillosis in Patients with Acute Leukemia: Comparison Between Acute Myeloid and Acute Lymphoid Leukemia. Mycopathologia. 2023;188(1-2):1-8. 10.1007/s11046-022-00684-z.

98. Dimopoulos MA, Moreau P, Augustson B, Castro N, Pika T, Delimpasi S, et al. Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Am J Hematol. 2023;98(1):E15-e9. 10.1002/ajh.26602.

99. Casagrande GMS, Silva MO, Reis RM, Leal LF. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. Int J Mol Sci. 2023;24(3). 10.3390/ijms24032505.

100. Tobias-Machado M, Ornellas AA, Hidaka AK, Medina LG, Mattos PAL, Besio RS, et al. Long-term oncological and surgical outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) in patients with penile cancer. Int Braz J Urol. 2023;49(5):580-9. 10.1590/s1677-5538.Ibju.2023.0065.

101. Andrade DAPd, Guimarães APG, Melo ACd, Nogueira-Rodrigues A, Gomes LM, Scaranti M, et al. Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil. Frontiers in Oncology. 2023;13. 10.3389/fonc.2023.1133277.

102. Julião M, Bruera E, Silva C, Calado J, Cruz M, Vaz M, et al. “Mãos de Conforto” (Hands of Comfort): A novel non-pharmacological intervention to ease agitation in elderly persons with dementia. Palliat Support Care. 2023:1-7. 10.1017/s147895152300007x.

103. da Silva FRM, Zapaterini JR, Grassi TF, Bidinotto LT, Fernandes AAH, Barbisan LF. Maternal dietary zinc status alters offspring female mammary gland development and response to acute 7,12-dimethylbenzanthracene insult. Biotech Histochem. 2023:1-12. 10.1080/10520295.2023.2196092.

104. Kinker GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, Pereira PHB, Carvalho MLR, et al. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas. Gut. 2023. 10.1136/gutjnl-2022-328697.

105. Pedro Amorim Neto D, Vitor Pereira de Godoy J, Tostes K, Pelegrini Bosque B, Vieira Rodrigues P, Aparecida Rocco S, et al. Metabolic Disturbances in the Gut-brain Axis of a Mouse Model of MPTP-induced Parkinsonism Evaluated by Nuclear Magnetic Resonance. Neuroscience. 2023. 10.1016/j.neuroscience.2023.06.010.

106. Pacheco ST, Donadio MD, Almeida F, O’Connor JM, de Miguel V, Dioca M, et al. Metastatic pheochromocytoma and paraganglioma: a retrospective multicentre analysis on prognostic and predictive factors to chemotherapy. Ecancermedicalscience. 2023;17:1523. 10.3332/ecancer.2023.1523.

107. Moreno IAA, Oliveira DRd, Borçoi AR, Rissatti LF, Freitas FV, Arantes LMRB, et al. Methylation of BDNF gene in association with episodic memory in women. Frontiers in Neuroscience. 2023. 10.3389/fnins.2023.1092406.

108. Causin RL, Lengert AVH, Gomes INF, Freitas AJAd, Rosa MN, Reis RD, et al. MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression. Oncol Rep. 2023:1-22. 10.3892/or.2023.8546.

109. Nitecki R, Ramirez PT, Dundr P, Nemejcova K, Ribeiro R, Vieira Gomes MT, et al. MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial? Int J Gynecol Cancer. 2023. 10.1136/ijgc-2023-004711.

110. Cousseau CPV, Sorroche BP, de Jesus Teixeira R, de Carvalho AC, Melendez ME, de Castro Capuzzo R, et al. miR-99a-5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients. Head Neck. 2023. 10.1002/hed.27459.

111. Marta GN, Moraes FY, de Oliveira Franco RC, de Andrade Carvalho H, Gouveia AG, de Lima Gössling GC, et al. Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean. Rep Pract Oncol Radiother. 2023;28(3):340-51. 10.5603/RPOR.a2023.0046.

112. Pinto MT, Eiras Martins G, Vieira AGS, Galvão JMS, de Pádua Souza C, Macedo C, et al. Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review. Cancers (Basel). 2023;15(11). 10.3390/cancers15112990.

113. Peres SV, Arantes PE, Fagundes MA, Ab’Saber AM, Gimenes DL, Curado MP, et al. Molecular subtypes as a prognostic breast cancer factor in women users of the São Paulo public health system, Brazil. Rev Bras Epidemiol. 2023;26:e230028. 10.1590/1980-549720230028.

114. Bastos DA, Gongora ABL, Dzik C, Jardim DL, Piva M, Carcano FM, et al. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515). Clin Genitourin Cancer. 2023;21(3):e104-e13. 10.1016/j.clgc.2022.11.004.

115. Pádua Souza Cd, Carneiro ASB, Oliveira Lessa ACd, Lacerda DC, Paiva CE, Zorzetto MMC, et al. Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial. Research Square. 2023. 10.21203/rs.3.rs-2874299/v1.

116. Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, et al. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2023;41(18):3339-51. 10.1200/jco.22.01649.

117. Francisco LFV, da Silva RN, Oliveira MA, Dos Santos Neto MF, Gonçalves IZ, Marques MMC, et al. Occupational Exposures and Risks of Non-Hodgkin Lymphoma: A Meta-Analysis. Cancers (Basel). 2023;15(9). 10.3390/cancers15092600.

118. Alves MT, Cavalcanti A, Garavello I, Kososki E, Martins Silva EDFC. [Occupational performance and application of the International Classification of Functioning (ICF) in a rehabilitation service]. Rev Salud Publica (Bogota). 2023;21(3):307-16. 10.15446/rsap.V21n3.76011.

119. Pelorca RJF, de Oliveira-Junior I, da Costa Vieira RA. Oncoplastic surgery for Paget’s disease of the breast. Front Oncol. 2023;13:1151932. 10.3389/fonc.2023.1151932.

120. Lando L, Mallipatna A, Kletke SN, Gallie B. Orbital Complications and Cost Analysis of Enucleation by Myoconjunctival versus Conventional Techniques for Retinoblastoma. Ocular Oncology and Pathology. 2023:1-7. 10.1159/000531871.

121. Cappellano AM, Dassi N, Mançano B, Epelman S, Almeida DB, Cavalheiro S, et al. Outcome of Children and Adolescents With Primary Intracranial Germinoma Treated With Chemotherapy and Reduced Dose-Field Irradiation: A Prospective Brazilian Experience. JCO Glob Oncol. 2023;9:e2200257. 10.1200/go.22.00257.

122. Santos FA, Reis RM, Barroti LC, Pereira AAL, Matsushita MM, de Carvalho AC, et al. Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. J Gastrointest Cancer. 2023. 10.1007/s12029-023-00964-x.

123. Alves Martins BA, Filho OM, Ghezzi TL, Melani AGF, Romagnolo LGC, Moreira Júnior H, et al. An Overview of Robotic Colorectal Surgery Adoption and Training in Brazil. Medicina (Kaunas). 2023;59(9). 10.3390/medicina59091675.

124. Nassar-Reis JP, Umeta PF, Stefano JT, Longatto-Filho A, Carrilho FJ, Alves VAF, et al. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC. J Mol Histol. 2023. 10.1007/s10735-023-10142-9.

125. Kawasaki MK, Prado DDd, Fonseca DdSL, Faria Morato Ld, Altei WF, van Dams R, et al. Palliative stereotactic ablative body radiotherapy reirradiation for high volume head and neck cancer. Research Square. 2023. 10.21203/rs.3.rs-2781775/v1.

126. Zequim VC, Schick M, Gama RR, Gama MPR. Pancreatic adenocarcinoma is an exocrine malignant tumor which is responsible for > 90% of all pancreatic cancer. Endocrinologia & Diabetes Clínica e Experimental. 2023:2363 – 9.

127. Faria EF, Machado RD, Gualberto RJC, Milani MAV, Bidinotto LT, Machado MT, et al. Patient’s safety and satisfaction on same day discharge after robotic and laparoscopic radical prostatectomy versus discharge after 24 or 48 h: a longitudinal randomized prospective study. BMC Urol. 2023;23(1):149. 10.1186/s12894-023-01318-2.

128. Zantut-Wittmann DE, Barreto IS, Laus AC, Moreno DA, Moma CA, Maia FFR, et al. PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma. Mol Cell Endocrinol. 2023:111931. 10.1016/j.mce.2023.111931.

129. Sorroche BP, Teixeira RJ, Pereira CAD, Santana IVV, Vujanovic L, Vazquez VL, et al. PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil. Diagnostics (Basel). 2023;13(6). 10.3390/diagnostics13061041.

130. Hui D, Paiva BSR, Paiva CE. Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: “Care Anywhere, Anytime”. Curr Treat Options Oncol. 2023;24(1):1-11. 10.1007/s11864-022-01044-1.

131. van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, et al. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. J Cancer Surviv. 2023;17(4):1111-30. 10.1007/s11764-021-01160-1.

132. McNeil MJ, Godfrey A, Loggetto P, de Oliveira Junior A, Job G, Boldrini E, et al. Physician Perceptions of and Barriers to Pediatric Palliative Care for Children With Cancer in Brazil. JCO Glob Oncol. 2023;9:e2300057. 10.1200/go.23.00057.

133. Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Wyrwicz L, et al. A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus. Future Oncol. 2023. 10.2217/fon-2022-1149.

134. Polachini GM, de Castro TB, Smarra LFS, Henrique T, de Paula CHD, Severino P, et al. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction. Sci Rep. 2023;13(1):8588. 10.1038/s41598-023-34808-2.

135. Clavero E, Sanchez-Maldonado JM, Macauda A, Ter Horst R, Sampaio-Marques B, Jurczyszyn A, et al. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization. Int J Mol Sci. 2023;24(10). 10.3390/ijms24108500.

136. Valentino TCO, Paiva CE, de Oliveira MA, Hui D, Bruera E, Julião M, et al. Preference and actual place-of-death in advanced cancer: prospective longitudinal study. BMJ Support Palliat Care. 2023. 10.1136/spcare-2023-004299.

137. Pinheiro JdA, Borçoi AR, Vitorino Freitas F, Mendes SO, Archanjo AB, Oliveira MMd, et al. Psychotropic drug use and suggestive depression symptoms associated with NR3C1 DNA methylation. Revista brasileira de crescimento e desenvolvimento humano. 2023;33(1):139-52. 10.36311/jhgd.v33.14300.

138. Neuber AC, Komoto TT, da Silva ECA, Duval VDS, Scapulatempo-Neto C, Marques MMC. Quality Assessment of Cryopreserved Human Biological Samples from the Biobank of Barretos Cancer Hospital. Biopreserv Biobank. 2023;21(1):74-80. 10.1089/bio.2021.0131.

139. Carvalho TM, Lourenção LG, Pinto MH, Viana R, Moreira A, Mello LP, et al. Quality of life and work engagement among nursing staff at the start of the COVID-19 pandemic. Cien Saude Colet. 2023;28(10):2903-13. 10.1590/1413-812320232810.09982023.

140. Niederauer Ramos CR, Silva Oliveira RJ, Rosa MN, Pereira AS, de Abreu RBV, Helvoort Lengert AV, et al. RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors. Curr Cancer Drug Targets. 2023. 10.2174/1568009623666230418101511.

141. Ferreira CC. The relation between human papillomavirus (HPV) and oropharyngeal cancer: a review. PeerJ. 2023;11:e15568. 10.7717/peerj.15568.

142. Santos Carmo BD, de Camargos MG, Santos Neto MFD, Paiva BSR, Lucchetti G, Paiva CE. Relationship between religion/spirituality and the aggressiveness of cancer care: a scoping review. J Pain Symptom Manage. 2023. 10.1016/j.jpainsymman.2023.01.017.

143. García-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, et al. Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. J Thorac Oncol. 2023;18(3):313-23. 10.1016/j.jtho.2022.10.020.

144. Bakhoum CY, Madala S, Lando L, Yarmohammadi A, Long CP, Miguez S, et al. Retinal Ischemic Perivascular Lesions in Individuals With Atrial Fibrillation. J Am Heart Assoc. 2023;12(16):e028853. 10.1161/jaha.122.028853.

145. Yu SL, Hsiao YJ, Cooper WA, Choi YL, Avilés-Salas A, Chou TY, et al. The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer. Pathology. 2023;55(1):19-30. 10.1016/j.pathol.2022.07.016.

146. Cibula D, Akilli H, Jarkovsky J, van Lonkhuijzen L, Scambia G, Meydanli MM, et al. Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study. Gynecol Oncol. 2023;170:195-202. 10.1016/j.ygyno.2023.01.014.

147. de Oliveira C, Gonçalves PG, Bidinotto LT. Role of EGFL7 in human cancers: A review. J Cell Physiol. 2023. 10.1002/jcp.31084.

148. Ferreira CDC, Gama RR, De Carvalho AC, Santana I, Carvalho RS, Debora SDA, et al. Role of Genetic Ancestry in Oropharyngeal Squamous-Cell Carcinoma: A Cross-Sectional Study in Brazil. Journal of Biosciences Medicines. 2023;11(1):150-61. 10.4236/jbm.2023.111015.

149. de Oliveira WE, Jr., Murra MS, Tufi LMB, Cavalcante CEB, de Oliveira MA, da Costa RFA, et al. Sarcopenia in Children With Wilms Tumor: A Marker of Undernutrition Which May Impact Adversely on Clinical Outcomes. J Pediatr Hematol Oncol. 2023. 10.1097/mph.0000000000002732.

150. Hermoza AD, Noleto R, Chubassi W, Pires L, da Cunha Andrade CEM, Dos Reis R. Secondary surgical cytoreduction of thoracic metastasis in a high grade serous ovarian carcinoma by video-assisted thoracoscopic surgery (VATS) in 10 steps. Gynecol Oncol Rep. 2023;46:101146. 10.1016/j.gore.2023.101146.

151. Vieira RAdC, Campos RES, Amorim MA, Silveira AD, Oliveira LCNd, José SA. Sequels associated with breast cancer treatment: what is important to measure in a report. Mastology. 2023;33:1-6. 10.29289/2594539420220050.

152. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View. Healthcare (Basel). 2023;11(6). 10.3390/healthcare11060906.

153. Cabral ERM, Pacanhella MF, Lengert AVH, Dos Reis MB, Leal LF, de Lima MA, et al. Somatic mutation detection and KRAS amplification in testicular germ cell tumors. Front Oncol. 2023;13:1133363. 10.3389/fonc.2023.1133363.

154. Bizzarri N, Querleu D, Dostalek L, van Lonkhuijzen L, Giannarelli D, Lopez A, et al. Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a sub-analysis of the SCCAN collaborative study. Am J Obstet Gynecol. 2023. 10.1016/j.ajog.2023.06.030.

155. Oliveira AGS, Rocha MA, de Azevedo LS, Coelho ATM, Chagas RCR, Santos HB, et al. Tapirira guianensis is Selectively Cytotoxic, Induces Apoptosis to the Glioblastoma and Decreases Tumor Growth and Angiogenesis in vivo. Planta Med. 2023. 10.1055/a-2181-2569.

156. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F. Thyroid Cancer Incidence and Mortality by Socioeconomic Level in the State of São Paulo, Brazil 2001-2017. Endocr Pract. 2023. 10.1016/j.eprac.2023.07.028.

157. Paiva CE, Preto DD, de Lima C, Paiva BSR. To Treat or Not to Treat? Dilemmas when Deciding on Antineoplastic Treatment in Patients With Far Advanced Cancers. Cancer Control. 2023;30:10732748231176639. 10.1177/10732748231176639.

158. Quaioto BR, Borçoi AR, Mendes SO, Doblas PC, Dos Santos Vieira T, Arantes Moreno IA, et al. Tobacco use modify exon IV BDNF gene methylation levels in depression. J Psychiatr Res. 2023;159:240-8. 10.1016/j.jpsychires.2023.01.038.

159. Uchida Miwa M, Paiva CE, Ferreira AJS, Julião M, Chochinov HM, Paiva BSR. Translation and cross-cultural adaptation of the Dignity Therapy Question Protocol to Brazilian Portuguese. Palliat Support Care. 2023:1-7. 10.1017/s147895152300041x.

160. Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, et al. Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary. Future Oncol. 2023. 10.2217/fon-2022-1294.

161. Goveia L, Castro N, de Souza C, Colaço Villarim C, Traina F, Chiattone CS, et al. Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry. Ann Hematol. 2023. 10.1007/s00277-023-05352-w.

162. Gomes BC, Lobo SMA, LM SM, de Freitas Chaves RC, Domingos Corrêa T, Prata Amendola C, et al. Trends in perioperative practices of high-risk surgical patients over a 10-year interval. PLoS One. 2023;18(9):e0286385. 10.1371/journal.pone.0286385.

163. André T, Falcone A, Shparyk Y, Moiseenko F, Polo-Marques E, Csöszi T, et al. Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study. Lancet Gastroenterol Hepatol. 2023;8(2):133-44. 10.1016/s2468-1253(22)00334-x.

164. Donadel CD, Pires BG, André NC, Costa TCM, Orellana MD, Caruso SR, et al. Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease. Pharmaceuticals (Basel). 2023;16(4). 10.3390/ph16040512.

165. Sales KDS, de Matos Mota AG, Gusmão CTP, Ribeiro Junior HL. Uncommon Foot Pain: A Rare Case of Sequential Migration of Cutaneous Pili Migrans. Int J Trichology. 2023;15(1):33-5. 10.4103/ijt.ijt_4_21.

166. Garcia ALH, de Souza MR, Picinini J, Soares S, Rohr P, Linden R, et al. Unraveling gene expression and genetic instability in dental fluorosis: Investigating the impact of chronic fluoride exposure. Sci Total Environ. 2023;906:167393. 10.1016/j.scitotenv.2023.167393.

167. Wang W, Kumm ZT, Ho C, Zanesco-Fontes I, Texiera G, Reis RM, et al. Unsupervised machine learning models reveal predictive markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. Res Sq. 2023. 10.21203/rs.3.rs-2834239/v1.

168. Sabaini P, Machado CM. Use of live viral vaccines after HCT: Still a lot to learn. Transpl Infect Dis. 2023:e14044. 10.1111/tid.14044.

169. Vazquez FdL, Silveira HCS, Otero UB, Hosokawa TT, Fregnani JHTG, Longatto-Filho A, et al. The Usefulness of an Online Simplified Screening Questionnaire (SSQ) in Identifying Work-Related Cancers. Healthcare. 2023;11(11):1563. 10.3390/healthcare11111563.

170. Ferreira NN, Miranda RR, Moreno NS, Pincela Lins PM, Leite CM, Leite AET, et al. Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy. Front Bioeng Biotechnol. 2023;11:1120179. 10.3389/fbioe.2023.1120179.

171. de Carvalho LGA, Komoto TT, Moreno DA, Goes JVC, de Oliveira RTG, de Lima Melo MM, et al. USP15-USP7 Axis and UBE2T Differential Expression May Predict Pathogenesis and Poor Prognosis in De Novo Myelodysplastic Neoplasm. Int J Mol Sci. 2023;24(12). 10.3390/ijms241210058.

172. Straus Takahashi M, Gustavo Ieiri Yamanari M, Henrique de Marqui Moraes P, Iglesias Lopes R, Chammas MC. Vesicoureteral reflux by contrast ultrasound, comparison with voiding and retrograde urethrocystography: A prospective accuracy study. J Pediatr Urol. 2023. 10.1016/j.jpurol.2023.10.014.

173. Trevizan FB, Paiva CE, de Almeida LF, de Oliveira MA, Bruera E, Paiva BSR. When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2023:1-9. 10.1017/s1478951523001517.